Ceres Nanosciences
Biotechnology, 9460 Innovation Dr, MANASSAS, Virginia, 20110, United States, 11-50 Employees
Phone Number: 80********
Who is CERES NANOSCIENCES
Ceres Nanosciences Inc. ("Ceres") is a privately held life sciences company engaged in the research, development, and commercialization of innovative sample preparation products, based on...
Read More
-
Headquarters: 9460 Innovation Dr, MANASSAS, Virginia, 20110, United States
-
Date Founded: 2008
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
-
CEO:
Ross Dunlap
Email
Phone
Industry: Biotechnology
SIC Code: 8731
|
NAICS Code: 541714 |
Show More
Does something look wrong? Fix it. | View contact records from CERES NANOSCIENCES
Ceres Nanosciences Org Chart and Mapping
Similar Companies to Ceres Nanosciences
AstraZeneca
-
10001+
-
$ 1 Billion and Over
Bio Nebraska
-
1-10
-
$ Under 1 Million
Bio-Rad Laboratories
-
5001-10000
-
$ 1 Billion and Over
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Ceres Nanosciences
Answer: Ceres Nanosciences's headquarters are located at 9460 Innovation Dr, MANASSAS, Virginia, 20110, United States
Answer: Ceres Nanosciences's phone number is 80********
Answer: Ceres Nanosciences's official website is https://ceresnano.com
Answer: Ceres Nanosciences's revenue is $10 Million to $25 Million
Answer: Ceres Nanosciences's SIC: 8731
Answer: Ceres Nanosciences's NAICS: 541714
Answer: Ceres Nanosciences has 11-50 employees
Answer: Ceres Nanosciences is in Biotechnology
Answer: Ceres Nanosciences top competitors include: AstraZeneca , Bio Nebraska , Bio-Rad Laboratories
Answer: Ceres Nanosciences contact info: Phone number: 80******** Website: https://ceresnano.com
Answer: Ceres Nanosciences Inc. ("Ceres") is a privately held life sciences company engaged in the research, development, and commercialization of innovative sample preparation products, based on its proprietary Nanotrap technology. The Nanotrap technology, coupled with existing research and clinical diagnostic platforms, improves the sensitivity and accuracy of a wide array of critical diagnostic processes. Early detection of biomarkers, in particular those of low abundance, is key to the diagnosis and treatment of diseases such as cancer, cardiac, and infectious diseases, resulting in improved patient benefit and reduced health care costs. Ceres currently sells the Nanotrap technology for use in a broad range of research and diagnostic applications.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month